New FDA Label Touts Chantix Safety; Pfizer Pushes to Remove Black Box

The FDA updated the label of Pfizer's anti-smoking drug Chantix to include data from a number of recent studies that found little to no evidence of psychiatric problems or suicidal tendencies in patients taking the drug.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news